< Terug naar vorige pagina
Onderzoeker
Charlotte Rigauts
- Trefwoorden:Anti-inflammatoire bacteriën
- Disciplines:Microbioom, Immunologie niet elders geclassificeerd
Affiliaties
- Vakgroep Farmaceutische Analyse (Departement)
Lid
Vanaf1 jul 2015 → 31 dec 2021
Projecten
1 - 1 of 1
- Nieuwe anti-inflammatorische therapieën op basis van het
mucoviscidose longmicrobioomVanaf1 jan 2017 → 31 dec 2020Financiering: FWO Strategische Onderzoeksbeurs
Publicaties
1 - 5 van 5
- Commensal bacteria of the lung microbiota synergistically inhibit inflammation in a three-dimensional epithelial cell model(2023)
Auteurs: Ellen Goeteyn, Lucia Grassi, Sara Van den Bossche, Charlotte Rigauts, Yannick Vande Weygaerde, Eva Van Braeckel, Ken Bracke, Aurélie Crabbé
- Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease(2022)
Auteurs: Charlotte Rigauts, Juliana Aizawa, Steven Taylor, Geraint B. Rogers, Matthias Govaerts, Paul Cos, Lisa Ostyn, Sarah Sims, Eva Vandeplassche, Mozes Sze, et al.
- Exploring the effects of non-pathogenic respiratory microbiome members on inflammation in models of chronic airway disease(2020)
Auteurs: Charlotte Rigauts
- Host metabolites stimulate the bacterial proton motive force to enhance the activity of aminoglycoside antibiotics(2019)
Auteurs: Aurélie Crabbé, Lisa Ostyn, Sorien Staelens, Charlotte Rigauts, Martijn Risseeuw, Maarten Dhaenens, Simon Daled, Heleen Van Acker, Dieter Deforce, Serge Van Calenbergh, et al.
- Influence of three-dimensional lung epithelial cells and interspecies interactions on antibiotic efficacy against Mycobacterium abscessus and Pseudomonas aeruginosa(2018)
Auteurs: Graciela Rodriguez-Sevilla, Charlotte Rigauts, Eva Vandeplassche, Lisa Ostyn, Ignacio Mahillo-Fernandez, Jaime Esteban, Concepcion Perez-Jorge Peremarch, Aurélie Crabbé